RecruitingNCT07172243

BE.Amycon Biobank & Data Registry UZ Leuven

BE.Amycon Biobank & Data Registry UZ Leuven: Human Body Material (HBM) Collection and Data Collection of Patients With Amyloidosis

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

505 participants

Start Date

Sep 24, 2025

Study Type

OBSERVATIONAL

Conditions

Amyloidosis AL Amyloidosis Amyloidosis Cardiac

Summary

The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database "BE.Amycon data registry".

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with al amyloidosis, amyloidosis, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.